Smith & Nephew's (SNN) CATALYSTEM System Gets FDA Clearance

Smith & Nephew (SNN) announces the receipt of FDA clearance for its new CATALYSTEM Primary Hip System, which is intended to address the demands of primary hip surgery.

Articles similaires

Clearmind Biomedical Announces FDA Clearance and First U.S. Surgery of the Neuroblade System for Minimally Invasive Neurosurgery

healthtechzone.com - 26/Aug 14:00

Zynex Stock Rises on FDA Clearance of Its New Pain Management Device

zacks.com - 04/Sep 12:32

ZYXI recently received the Food and Drug Administration clearance for its new TensWave device. TensWave is designed to provide a comprehensive pain...

Merakris Therapeutics Announces FDA Clearance for Part 2 of its Phase II Multicenter Investigational New Drug Study of Dermacyte® Liquid

healthtechzone.com - 05/Sep 10:30

Merakris Therapeutics Announces FDA Clearance for Part 2 of its Phase II Multicenter Investigational New Drug Study of Dermacyte® Liquid

healthtechzone.com - 05/Sep 10:30

QuidelOrtho Expands in Infectious Disease Testing With New FDA Nod

zacks.com - 30/Aug 15:53

QDEL announces the FDA's clearance for its VITROS syphilis assay, which boosts the company's infectious disease testing portfolio.

SI-BONE (SIBN) Receives FDA Nod for Its TNT Implant System

zacks.com - 26/Aug 12:19

SI-BONE (SIBN) receives FDA 510(k) clearance for its iFuse TORQ TNT implant system, followed by a Breakthrough Device Designation award by the FDA.

Noble Corporation and Diamond Offshore provide update on expected closing of transaction

energy pedia.com - 31/Aug 05:03

Noble Corporation and Diamond Offshore have announced the receipt of clearance from the Australia Competition & Consumer Commission in relation to the...

Kangana Ranaut's Emergency gets postponed, won't release on Sept 6

times of india - 01/Sep 15:04

Kangana Ranaut's upcoming film Emergency will not be released on September 6 as planned due to ongoing controversies. The film is still awaiting...

Zynex Obtains FDA clearance for new Pain Management Device

healthtechzone.com - 03/Sep 13:15

KalVista announces FDA acceptance of NDA for sebetralstat for oral on-demand treatment of HAE

haei.org - 03/Sep 17:29

KalVista announces FDA acceptance of New Drug Application for sebetralstat for oral on-demand treatment of hereditary angioedema KalVista...

Les derniers communiqués

Adobe Brings Conversational AI to Trillions of PDFs with the New AI Assistant in Reader and Acrobat
Adobe - 21/02/2024
Laura Frigenti takes the Helm as Chief Executive Officer of the Global Partnership for Education
Global Partnership for Education - 05/12/2022

Rubriques :

Articles similaires

Les derniers communiqués